R. Crowe et al., AN INCREASE OF NEUROPEPTIDE-Y BUT NOT NITRIC-OXIDE SYNTHASE-IMMUNOREACTIVE NERVES IN THE BLADDER NECK FROM MALE-PATIENTS WITH BLADDER NECK DYSSYNERGIA, The Journal of urology, 154(3), 1995, pp. 1231-1236
Purpose To determine the distribution of neuropeptides in male patient
s with bladder neck dyssynergia and benign prostatic hyperplasia. Mate
rials and Methods: Bladder neck tissue, obtained from male patients wi
th bladder neck dyssynergia (END) and control patients with benign pro
static hyperplasia (BPH), was studied immunohistochemically for protei
n gene product 9.5 (a general neuronal marker), vasoactive intestinal
polypeptide, neuropeptide Y, calcitonin gene-related peptide, substanc
e P, growth associated protein 43 and nitric oxide synthase. Results:
In the bladder neck from control patients, the greatest density of ner
ves contained protein gene product 9.5, followed in decreasing order b
y neuropeptide Y; vasoactive intestinal polypeptide; calcitonin gene-r
elated peptide; nitric oxide synthase; substance P and serotonin. The
neuropeptides were found in the smooth muscle and were also associated
with blood vessels. In patients with END there was a statistically si
gnificant increase (P < 0.05) in the density of protein gene product 9
.5- and neuropeptide Y-immunoreactive nerves in the smooth muscle and
the base of the mucosa but not in blood vessels in the bladder neck, w
hile the density of the other neuropeptides studied, nitric oxide synt
hase and serotonin did not significantly change from that of control t
issue. Growth associated protein 43-immunoreactive nerves were absent
from the bladder neck from both groups of patients. Conclusion: It is
suggested that the increase in density of protein gene product 9.5- an
d neuropeptide Y-immunoreactive nerves, part of the sympathetic contra
ctile system of the bladder neck, may exacerbate bladder outlet obstru
ction and thus play a role in the pathogenesis of BND.